ghk cu injectable human clinical trial GHK-Cu Peptide GHK-Cu Peptide for Skin Rejuvenation
Description
BMC Endocr
Martinon et al
, GHK-Cu - -
RESULTS AND DISCUSSION In this study, we continued the investigation of the biological properties of several peptide analogs of DSIP and KND, primarily in a context of a decrease in toxicity of the anticancer treatment on the model of the cisplatin-induced toxicosis
However, this may only partially be achievable due to the underlying pathophysiology of the disease
Monitoring Progress and Adjusting Protocols Objective assessment of AOD-9604s effects requires proper measurement tools and regular evaluation
